Konferenzen  >  Medizin & Gesundheitswesen  >  Infektiologie

European Society for Translational Medicine (EUSTM)

The European Society for Translational Medicine (EUSTM) cordially invites you to attend the 9th Annual Congress of the European Society for Translational Medicine on Immunotherapeutics – From Biology to Patient Care (EUSTM-2022) held in virtual format during 3-5 October, 2022. Due to the COVID-19 Corona virus pandemic, the European Society for Translational Medicine (EUSTM) has revised the 2022 congress format to a virtual event. EUSTM took this initiative to ensure the health and safety of our global delegates. This Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care. EUSTM-2022 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.

European Society for Translational Medicine;     Tel.: [+43 1 8923 562];     Email: eustm-2022@eutranslationalmedicine.org

solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, vaccines, Translational Medicine, Medicine, Immunotherapeutics, Immunobiology, biological research, diagnostics & biomarkers, clinical care, Celular Biology, Molecular Biology, Blood Cancer, Atopic Dermatitis, Public Health

Onkologie,    Immunologie und Allergie

Ashfield Healthcare Communications

The HIV Glasgow programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focused on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community.

Tel.: [+44 (0) 1625 817059];     Email: hivglasgow@ashfieldhealthcare.com

HIV, Drug Therapy, Infectious Diseases

Harvard Medical School

This acclaimed course, among the highest-rated Harvard Medical School CME courses, provides a comprehensive ID update especially for primary care practitioners. Led by Harvard Medical School's leading ID faculty and clinicians, this program provides guidance to improve the diagnosis, prevention, and treatment of infectious diseases. Participants learn the practice implications of important new innovations and ensure that their ability to address ID challenges is fully current.

Harvard Medical School Postgraduate Medical Education;     Tel.: [617-384-8600];     Email: CEPrograms@hms.harvard.edu

Harvard, CME, Immunizations, Lyme, COVID-19, infection, vaccine, HIV, MRSA, Hepatitis, UTI, STI, pneumonia, flu, gastroenteritis, travel medicine, respiratory, coronavirus, C. difficile, H. pylori, antibiotics, antibiotic allergy, tuberculosis, respiratory

Medizin (allgem.), Innere Medizin,    Fortbildung für Gesundheitsfachberufe (CME)

Immunologie und Allergie,    Epidemiologie

The Physical Virology GRS provides a unique forum for young doctoral and post-doctoral researchers to present their work, discuss new methods, cutting edge ideas, and pre-published data, as well as to build collaborative relationships with their peers. Experienced mentors and trainee moderators will facilitate active participation in scientific discussion to allow all attendees to be engaged participants rather than spectators. Emphasis on cross disciplinary approaches that deepen our understanding of virus assembly, structure and function will be highlighted, followed by how these advances have recently been applied to innovations ranging from nanomaterials to novel therapeutics.

Examining Viral Particles Across Multiple Platforms as Virology Shapes the Development of Biomaterials

Biologie,    Biophysik

A deep immunological understanding of fungal infections is crucial in order to reduce the fungal impact on human health. Advances in the field of fungal immunology over the past few years have identified crucial factors that predispose patients to fungal infections, including genetic factors. Essential pathways in mucosal and systemic immune responses to fungi have been uncovered. Most importantly, the increasing knowledge in the immunology of fungal infections has initiated the development of novel therapeutic strategies aimed at improving antifungal immunity or suppressing detrimental immune pathways. Despite these advances, many questions about the complex interaction of fungi, microbiome, and immune system remain unanswered. Therefore, the Gordon Research Seminar provides a platform for early career scientists to build collaborations with clinicians and industry in order to translate fundamental research into personalized medicine and diagnostics for fungal infections.

Modeling Antifungal Host Defense to Impact Therapy and Management of Infections

Biologie,    Immunologie und Allergie

At the global level, viral epidemiology depends on modes of transmission and social networks; at the cellular level viruses repurpose protein interaction networks and remodel cellular compartments; on the local level the assembly and disassembly of a virus is governed by (and reveals) physical principles. Viruses also bridge multiple scientific disciplines. In biomedicine, understanding viral lifecycles provides essential information for developing antiviral agents that block infection. In more fundamental sciences, viruses are ideal model systems for studying mechanisms underlying self-assembly, genome packaging and release, allostery, membrane dynamics, and the efficient passage of nanoscale particles through membranes. The COVID-19 pandemic highlights the need for these cross-disciplinary approaches to understand viral biology, predict their global spread in impact, and develop new treatments. In addition to advancing antiviral strategies and cell biology, the knowledge acquired from these studies and the viral particles themselves are enabling researchers to engineer virus-based platforms for biomedical and nanomaterials applications, such as gene delivery or optoelectronics. This natural diversity requires collaborative efforts of researchers with a wide range of expertise.

Viruses at Multiple Levels of Complexity

Biologie,    Biophysik

The 2023 Gordon Research Conference on the Immunology of Fungal Infections will focus on leading advances in our mechanistic understanding of the immune response against clinically relevant fungal pathogens. This meeting – the 6th in its series – has become the must-attend venue for immunologists and medical mycologists to discuss how the immune system responds to the challenge of fungal organisms as well as how the fungal species subvert the innate and adaptive immune system.

Advancing Care Through Fundamental Discovery

Biologie,    Immunologie und Allergie

The focus of this edition is to shed light on the importance of transdisciplinary approaches to prevent the next pandemic, especially concerning tropical infectious diseases and their treatments. Young scientists will have the opportunity to showcase their research projects in oral or poster presentations. The GRS will conclude with an interactive, diverse career panel to discuss traditional and non-traditional career options as well as funding options in biomedical research and how scientists can effectively communicate their research. Following the GRS, participants are highly encouraged to apply and attend the Gordon Research Conference (GRC) on Tropical Infectious Diseases, which will highlight transdisciplinary approaches to advance in tropical infectious diseases health technologies.

Advances in Tropical Infectious Diseases: From Bench to Clinic

The 2023 Gordon Research Conference on Tropical Infectious Diseases will present cutting edge research on the most prevalent and medically important tropical infectious and emerging diseases (TIEDs). It will have a thematic organization similar to the conferences held in 2015, 2017 and 2019. The intent is to gather a multidisciplinary community of scientists and discuss cutting edge basic, field-based, translational and clinical research in TIEDs.

Transdisciplinary Approaches to Advance Tropical Infectious Diseases Health Technologies

This meeting will bring together research that encompasses basic and translational virology. We envision this meeting showcasing the ubiquity of viruses while highlighting commonalities among researchers, from technology through a standard goal of understanding how viruses behave and adapt and how this may be exploited for prediction of the next outbreak or leveraged for therapeutic development.

European Molecular Biology Laboratory | EMBL

BioMalPar XIX will showcase the multidisciplinary nature of malaria research with a programme that welcomes clinical malaria, epidemiological studies, immunology, and evolution and ecology alongside core BioMalPar topics. The programme focuses on early-mid career researchers to help mitigate the effects of the COVID-19 pandemic which have been particularly acute for these stages.

The meeting will explore bacterial pathogens and pathogenesis from multiple perspectives, from cellular mechanisms to interbacterial interactions and community behavior, as well as pathogenesis in the complex milieu of the microbiota. The meeting will also highlight the pathogenic potential of the microbiome and explore microbiota-based and engineered antibacterial/therapeutic approaches.

Pharmakologie und Arzneimittelentwicklung,    Biologie

This conference regularly attracts over 500 scientists, with representatives from many of the major research groups in this area worldwide. If you want to meet many of your peers in this field, this is the place to go.